Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03269149 · ClinicalTrials.gov registry record · NA

Tango for Alzheimer's Disease Patients' Caregivers

A NA study of Alzheimers Disease, sponsored by Emory University.

Active
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT03269149: Active NA study of Alzheimers Disease, sponsored by Emory University.

NCT03269149 is a NA study of Alzheimers Disease that is active but no longer recruiting, run by Emory University. The registered enrollment target is 60 participants, below the 3,926-participant average among 147 other Alzheimers Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03269149, a NA study of Alzheimers Disease, is active but no longer recruiting, sponsored by Emory University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The goal of the project is to determine the extent to which indices of inflammatory biomarkers, cognition and mood, are influenced by a partnered, dance-based intervention vs control condition in African American (AA) female family caregivers, at high risk for Alzheimer's disease (AD).

Primary Outcome

45 mL blood will be acquired before and after the intervention to measure the inflammatory and stress marker levels

Conditions Studied

Alzheimers Disease

Interventions

  • OTHER Adapted Tango Dance
  • BEHAVIORAL Educational lectures

Study Locations (1)

Georgia

  • Atlanta VA Medical Center, Emory University, Executive Park, Wesley Woods - Atlanta

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2017-09-19
Est. Completion 2026-04
Phase NA
Emory University

1,208 total trials

What the registry record for NCT03269149 still lists

NCT03269149 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 3,926-participant average among 147 other Alzheimers Disease trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Alzheimers Disease appearing as the primary indexed condition, and to 2 interventions - of which Adapted Tango Dance is the first listed.

NCT03269149 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT03269149 about?

NCT03269149 is a clinical study titled "Tango for Alzheimer's Disease Patients' Caregivers". The goal of the project is to determine the extent to which indices of inflammatory biomarkers, cognition and mood, are influenced by a partnered, dance-based intervention vs control condition in African American (AA) female family caregivers, at high risk for Alzheimer's disease (AD).

What is the current status of trial NCT03269149?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2017-09-19. Estimated completion is 2026-04.

What conditions does trial NCT03269149 study?

This clinical trial studies the following conditions: Alzheimers Disease.

What interventions are being tested in trial NCT03269149?

The interventions under investigation include: Adapted Tango Dance (OTHER), Educational lectures (BEHAVIORAL).

Who is sponsoring clinical trial NCT03269149?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03269149 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alzheimers Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03269149's enrollment target sits among peer trials

60 86th of 147 higher than 59 of 147 other Alzheimers Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alzheimers Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT03269149, the US trial registry maintained by the National Library of Medicine. NCT03269149 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.